Clinical trial

COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes

NCT04723550

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-01-05

PhaseNA

Study timeline

Study start (actual)2021-01-05Date precision: day

Registry last updated2021-01-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

Hospital telemedicine management systemDEVICE

Usual careOTHER

Sponsors & collaborators

Wenwen Yinlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04723550 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.